NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4173-4200
Author(s):
Javadi Monisha, Ganesan Padmavathi, Nand Kishor Roy, Anindita Deka, Devivasha Bordoloi, Anand Anip and Ajaikumar B. Kunnumakkara
O-6-methylguanine-DNA Methyltransferase Inhibits Gastric Carcinoma Cell Migration and Invasion by Downregulation of Matrix Metalloproteinase 2
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
1125-1132
Author(s):
Chenglong Li, Li Deng, Hugang Shen, Qingyou Meng, Aimin Qian, Hongfei Sang, Jiazeng Xia and Xiaoqiang Li
Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4160-4172
Author(s):
Indu Pal Kaur, Parneet Kaur Deol, Kanthi Kiran Kondepudi and Mahendra Bishnoi
The Role of Stromal Components in Pancreatic Cancer Progression
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
1117-1124
Author(s):
Mengdan Xu, Binhua P. Zhou, Min Tao, Jingyi Liu and Wei Li
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
Journal:
MicroRNA
Volume:
5
Page:
12-18
Author(s):
Anna Truini*, Simona Coco, Carlo Genova, Marco Mora, Maria G. Dal Bello, Irene Vanni, Angela Alama, Erika Rijavec, Giulia Barletta, Federica Biello, Claudia Maggioni and Francesco Grossi
Time Dependent Distribution of MicroRNA 144 after Intravenous Delivery
Journal:
MicroRNA
Volume:
5
Page:
36-49
Author(s):
Jing Li, Sean Cai, Jenny Peng, Mark K. Friedberg and Andrew N. Redington
Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
Journal:
MicroRNA
Volume:
5
Page:
5-11
Author(s):
Cinzia Ciccacci*, Cristina Politi, Giuseppe Novelli and Paola Borgiani
MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
618-630
Author(s):
Hoang-Lan Nguyen, Pournima Kadam, Alex Helkin, Kevin Cao, Song Wu, Ghassan J. Samara, Qian Zhang, Stanley Zucker and Jian Cao
Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
631-638
Author(s):
Xiaojuan Wu, Hui Xiao, Ruoning Wang, Lingling Liu, Chenglong Li and Jiayuh Lin
nMET, A New Target in Recurrent Cancer
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
572-578
Author(s):
Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang